This study aims to evaluate the protective effects of ω-3 fatty acids (FAs) on doxorubicin (DOX)-induced hepatotoxicity and nephrotoxicity in rats. A total of 24 adult male Sprague Dawley rats were divided into three groups. Control group was given only saline by intragastric gavage. DOX group received DOX at the dose of 30 mg/kg intraperitoneally on day 28. DOX-ω-3 FA group was given as ω-3 FAs at the dose of 400 mg/kg daily by intragastric gavage for 30 days and received DOX at the dose of 30 mg/kg intraperitoneally on day 28. At the end of the 30-day experimental period, the serum, liver and kidney tissue specimens were taken from the animals by giving a general anesthesia. Glutathione (GSH) and malondialdehyde (MDA) levels in serum and GSH and MDA levels and superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities in liver and kidney tissues were measured spectrophotometrically. In our study, a significant increase in MDA levels was observed in rats when given a dose of DOX and a significant decrease in the levels of GSH, SOD and GSH-Px activities in serum, liver and kidney tissues was determined when compared with control group. In addition, a significant decrease in MDA levels was observed in rats when a dose of ω-3 FAs was given with DOX and a significant increase was determined in the levels of GSH, SOD and GSH-Px activities in serum, liver and kidney tissues, when compared with DOX group. We concluded that ω-3 FA had favorable effects in rat liver and kidney tissues by preventing oxidative damage.
Al-GayyarMMShamsMEBarakatEA (2012) Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease. Pharmaceutical Biology50: 297–303.
2.
AzambujaEFleckJFBatistaRG. (2005) Bleomycin lung toxicity: who are the patients with increased risk?Pulmonary Pharmacology and Therapeutics18: 363–366.
3.
BaydasGYilmazOCelikS. (2002) Effects of certain micronutrients and melatonin on plasma lipid, lipid peroxidation, and homocysteine levels in rats. Archives of Medical Research33: 515–519.
4.
BeutlerEDuronOKellyBM (1963) Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine61: 882–888.
5.
BouzidiNMekkiKBoukaddoumA. (2010) Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia. Journal of Renal Nutrition20: 321–328.
6.
BuegeJAAustSD (1978) Microsomal lipid peroxidation. Methods in Enzymology52: 302–310.
7.
BulucuFOcalRKaradurmusN. (2009) Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity. Biological Trace Element Research132: 184–196.
8.
BurnsCPNorthJA (1986) Adriamycin transport and sensitivity in fatty acid-modified leukemia cells. Biochimica et Biophysica Acta888: 10–17.
9.
BurnsCPSpectorAA (1994) Biochemical effects of lipids on cancer therapy. Journal of Nutritional Biochemistry5: 114–123.
10.
ChautanMCalafRLeonardiJ. (1990) Inverse modifications of heart and liver alpha-tocopherol status by various dietary n−6/n−3 polyunsaturated fatty acid ratios. Journal of Lipid Research31: 2201–2208.
11.
DeepaPRVaralakshmiP (2005) Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment. Chemico-Biological Interactions156: 93–100.
12.
DemozAWillumsenNBergeRK (1992) Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids27: 968–971.
13.
El-MeseryMAl-GayyarMSalemH. (2009) Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Cell Division4: 6.
14.
FadilliogluEErdoganHSogutS. (2003) Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. Journal of Applied Toxicology23: 71–74.
15.
GrimmHMertesNGoetersC. (2006) Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. European Journal of Nutrition45: 55–60.
16.
InjacRBoskovicMPerseM. (2008) Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress. Pharmacological Reports60: 742–749.
17.
IrazMErdoganHOzyurtB. (2005) Brief communication: omega-3 essential fatty acid supplementation and erythrocyte oxidant/antioxidant status in rats. Annals of Clinical and Laboratory Science35: 169–173.
18.
KalaiselviPPragasamVChinnikrishnanS. (2005) Counteracting adriamycin-induced oxidative stress by administration of N-acetyl cysteine and vitamin E. Clinical Chemistry and Laboratory Medicine43: 834–840.
19.
KalenderYYelMKalenderS (2005) Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin. Toxicology209: 39–45.
20.
KansalSNegiAKKaurR. (2011) Evaluation of the role of oxidative stress in chemopreventive action of fish oil and celecoxib in the initiation phase of 7,12-dimethyl benz(alpha)anthracene-induced mammary carcinogenesis. Tumour Biology32: 167–177.
21.
KhanMWPriyamvadaSKhanSA. (2012a) Protective effect of omega-3 polyunsaturated fatty acids (PUFAs) on sodium nitroprusside-induced nephrotoxicity and oxidative damage in rat kidney. Human and Experimental Toxicology31: 1035–1049.
22.
KhanMWPriyamvadaSKhanSA. (2012b) Protective effect of omega-3 polyunsaturated fatty acids on l-arginine-induced nephrotoxicity and oxidative damage in rat kidney. Human and Experimental Toxicology31: 1022–1034.
23.
KollerMSenkalMKemenM. (2003) Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clinical Nutrition22: 59–64.
24.
LawrenceRABurkRF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochemical and Biophysical Research Communications71: 952–958.
25.
LiangBWangSYeYJ. (2008) Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World Journal of Gastroenterology14: 2434–2439.
26.
LiuLLLiQXXiaL. (2007) Differential effects of dihydropyridine calcium antagonists on doxorubicin-induced nephrotoxicity in rats. Toxicology231: 81–90.
27.
ManouryBNenanSLeclercO. (2005) The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respiratory Research6: 11.
28.
MastersC (1996) Omega-3 fatty acids and the peroxisome. Molecular and Cellular Biochemistry165: 83–93.
29.
MeloJUSantosJMKimura OdeS. (2010) Effects of fatty acids on liver regeneration in rats. Revista do Collegio Brasileiro de Cirurgioes37: 351–357.
30.
MimnaughEGTrushMAGramTE (1986) A possible role for membrane lipid peroxidation in anthracycline nephrotoxicity. Biochemical Pharmacology35: 4327–4335.
31.
MylroieAACollinsHUmblesC. (1986) Erythrocyte superoxide dismutase activity and other parameters of copper status in rats ingesting lead acetate. Toxicology and Applied Pharmacology82: 512–520.
32.
OhkawaHOhishiNYagiK (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry95: 351–358.
33.
PrahalathanCSelvakumarEVaralakshmiP (2005) Protective effect of lipoic acid on adriamycin-induced testicular toxicity. Clinica Chimica Acta360: 160–166.
34.
PritsosCAMaJ (2000) Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity. Chemico Biological Interactions127: 1–11.
35.
PriyamvadaSKhanSAKhanMW. (2010) Studies on the protective effect of dietary fish oil on uranyl-nitrate-induced nephrotoxicity and oxidative damage in rat kidney. Prostaglandins Leukot Essent Fatty Acids82: 35–44.
36.
SaadSYNajjarTAAl-RikabiAC (2001) The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacological Research43: 211–218.
37.
SchauderPRohnUSchaferG. (2002) Impact of fish oil enriched total parenteral nutrition on DNA synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period. British Journal of Nutrition87(Suppl 1): S103–S110.
38.
SingalPKIliskovicNLiT. (1997) Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB Journal11: 931–936.
39.
SiriwardhanaNKalupahanaNSMoustaid-MoussaN (2012) Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Advances in Food and Nutrition Research65: 211–222.
40.
SmithPKKrohnRIHermansonGT. (1985) Measurement of protein using bicinchoninic acid. Analytical Biochemistry150: 76–85.
41.
StehbensWE (2003) Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc. Experimental and Molecular Pathology75: 265–276.
42.
TakayamaFNakamotoKTotaniN. (2010) Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis. Journal of Oleo Science59: 407–414.
43.
TanedaSHondaKTomidokoroK. (2010) Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis. American Journal of Physiology Renal Physiology299: F1451–F1461.
44.
WeissGMeyerFMatthiesB. (2002) Immunomodulation by perioperative administration of n-3 fatty acids. British Journal of Nutrition87(Suppl 1): S89–S94.
45.
YehYCLaiHCTingCT. (2007) Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochemical Pharmacology74: 969–980.
